Main > ONCOLOGY (**) > Pancreas Cancer>MET *** > Treatment > Co: FR. I. Irinotecan Liposome+>***

---

Co: FR. I. Irinotecan Liposome+>***'s subsections
(*) CA Approval Date: 2017. 08.11
(*) EU Approval Date: 2016. 10.18
(*) USA Approval Date: 2015. 10.22
+FluoroUracil+Leucovorin
>Progression>Gemcitabine CT
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2016. 07.19.
TradeMark
TradeMark Web-Site

Co: FR. I. Irinotecan Liposome+>***'s products
This section has no products